
By Davit Kirakosyan
Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: upgrades at Avis Budget, Q2, bluebird bio, Equitrans Midstream, and Financial Services.
InvestingPro subscribers got this news first. Never miss another market-moving headline.
Avis Budget Group (NASDAQ:CAR) shares gained more than 2% yesterday after Deutsche Bank upgraded the company to Buy from Hold and raised its price target to $263.00 from $239.00, as InvestingPro reported in real time.
The firm mentioned that the stock has been "left behind without cause," and emphasized the upgrade's main focus on the company's valuation.
Furthermore, the bank highlighted a potential catalyst in the form of expected share repurchases in the latter half of the year. Shares have significantly underperformed comparable travel and leisure sub-sectors year-to-date, lagging behind by an average of 2,400 basis points. The firm believes that the stock could attract investors looking to buy reasonably priced laggards as the S&P 500 sits near a 9-month high.
Q2 (NYSE:QTWO) shares rose more than 5% yesterday after BTIG upgraded the company to Buy from Neutral with a price target of $36.00, highlighting its increasingly constructive view of the long-term outlook for the company.
The firm believes Q2’s guidance is now conservative and much of the potential downside has been stripped out, while growth upside is more tangible than in recent years.
Bluebird bio (NASDAQ:BLUE) shares jumped more than 6% premarket today after Barclays upgraded the company to Overweight from Equalweight and raised its price target to $8.00 from $7.00.
JPMorgan upgraded Intercorp Financial Services (NYSE:IFS) to Overweight from Neutral with a price target of $27.00.
Amid an endless firehose of market headlines, jump on the most important ones to fatten your profits: Always be the first to know with InvestingPro.
Start your free 7-day trial now.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.